Azo reduction of sulphasalazine in healthy volunteers.
1 A comparison of total sulphapyridine saliva concentrations resulting from administration of sulphapyridine and sulphasalazine at equimolar doses has been carried out. It is concluded that the extent of azo reduction of sulphasalazine to release sulphapyridine is complete in healthy volunteers. 2 An ampicillin course of treatment alters the azo reduction of sulphasalazine. The extent of cleavage is reduced by one third on average. There is no change in the rate of absorption of the release sulphapyridine. 3 An ampicillin course of treatment does not alter the disposition of sulphapyridine. The changes noted in acetyl conjugate plasma concentrations are entirely consistent with reduced availability of sulphapyridine.
D000667:Ampicillin / Q000494:pharmacology; D006801:Humans; D007408:Intestinal Absorption; D007422:Intestines / Q000382:microbiology; D008297:Male; D010084:Oxidation-Reduction; D012463:Saliva / Q000378:metabolism; D013427:Sulfapyridine / Q000378:metabolism; D012460:Sulfasalazine / Q000378:metabolism*
D012460:Sulfasalazine; D000667:Ampicillin; D013427:Sulfapyridine